SHARON TETLOW
CIK 1328565 · Acting CFO & Treasurer · last filed 2025-06-25
SHARON TETLOW is an Acting CFO & Treasurer who has filed 16 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for GPCR, was dated Jun 25, 2025. Current disclosed insider exposure totals $65.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$65.1K
4
16
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GPCR | Director | — | $42.93 | — | $0 | 2 | 2025-06-25 |
| DICE Therapeutics, Inc. (DICE) Delisted | Director | 0 | $47.55 | $0 | $0 | 3 | 2023-08-09 |
| CBIO | Director | 3,635 | $17.92 | $65.1K | $0 | 5 | 2021-07-02 |
| CELL GENESYS INC (CEGE) Delisted | SVP & CFO | 0 | — | — | $0 | 5 | 2009-10-15 |
Recent Filings
16 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-25 | GPCR | Grant (A) | — | $0 | EDGAR |
| 2024-06-27 | GPCR | Grant (A) | — | $0 | EDGAR |
| 2023-08-09 | DICE Therapeutics, Inc. (DICE) Delisted | Disp (D) | −49,841 | $0 | EDGAR |
| 2022-06-08 | DICE Therapeutics, Inc. (DICE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-09-16 | DICE Therapeutics, Inc. (DICE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-07-02 | CBIO | Grant (A) | — | $0 | EDGAR |
| 2020-07-02 | CBIO | Grant (A) | +1,703 | $0 | EDGAR |
| 2020-06-12 | CBIO | Grant (A) | — | $0 | EDGAR |
| 2020-04-03 | CBIO | Grant (A) | +1,932 | $0 | EDGAR |
| 2020-01-17 | CBIO | Grant (A) | — | $0 | EDGAR |